schliessen

Filtern

 

Bibliotheken

Cover Image

Non-steroidal anti-inflammatory drugs and cardiovascular risk: At crossroads

Byline: Michael E. Farkouh Author Affiliation: Peter Munk Chair in Multinational Clinical Trials, Peter Munk Cardiac Centre and the Heart and Stroke Richard Lewar Centre of Excellence, University of Toronto, Toronto, Ontario, Canada Article Note: (footnote) The author has indicated there are no conf... Full description

Journal Title: Trends in cardiovascular medicine 2015, Vol.25 (8), p.736-737
Main Author: Farkouh, Michael E., MD, MSc, FRCPC, FACC, FAHA
Format: Electronic Article Electronic Article
Language: English
Subjects:
Anti-Inflammatory Agents, Non-Steroidal - adverse effects
Arthritis
Aspirin
Blood platelets
Blood pressure
Cardiovascular
Cardiovascular diseases
Cardiovascular Diseases - etiology
Clinical trials
Cyclooxygenase 1 - metabolism
Cyclooxygenase 2 - metabolism
Drug dosages
Drug therapy
Female
Health risk assessment
Heart attacks
Humans
Hypotheses
Male
Mortality
Nonsteroidal anti-inflammatory drugs
Risk factors
Side effects
Studies
Thrombosis
Quelle: Alma/SFX Local Collection
Publisher: United States: Elsevier Inc
ID: ISSN: 1050-1738
Link: https://www.ncbi.nlm.nih.gov/pubmed/26404864
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_proquest_miscellaneous_1728256376
title: Non-steroidal anti-inflammatory drugs and cardiovascular risk: At crossroads
format: Article
creator:
  • Farkouh, Michael E., MD, MSc, FRCPC, FACC, FAHA
subjects:
  • Anti-Inflammatory Agents, Non-Steroidal - adverse effects
  • Arthritis
  • Aspirin
  • Blood platelets
  • Blood pressure
  • Cardiovascular
  • Cardiovascular diseases
  • Cardiovascular Diseases - etiology
  • Clinical trials
  • Cyclooxygenase 1 - metabolism
  • Cyclooxygenase 2 - metabolism
  • Drug dosages
  • Drug therapy
  • Female
  • Health risk assessment
  • Heart attacks
  • Humans
  • Hypotheses
  • Male
  • Mortality
  • Nonsteroidal anti-inflammatory drugs
  • Risk factors
  • Side effects
  • Studies
  • Thrombosis
ispartof: Trends in cardiovascular medicine, 2015, Vol.25 (8), p.736-737
description: Byline: Michael E. Farkouh Author Affiliation: Peter Munk Chair in Multinational Clinical Trials, Peter Munk Cardiac Centre and the Heart and Stroke Richard Lewar Centre of Excellence, University of Toronto, Toronto, Ontario, Canada Article Note: (footnote) The author has indicated there are no conflicts of interest.
language: eng
source: Alma/SFX Local Collection
identifier: ISSN: 1050-1738
fulltext: fulltext
issn:
  • 1050-1738
  • 1873-2615
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.3558898
LOCALfalse
PrimoNMBib
record
control
sourceidgale_proqu
recordidTN_cdi_proquest_miscellaneous_1728256376
sourceformatXML
sourcesystemPC
galeidA435974180
sourcerecordidA435974180
originalsourceidFETCH-LOGICAL-c418t-496292e3b5082f1a8db55392052875112fbe43e8f95cf820c035a176a263619f3
addsrcrecordideNp9Ul2L1TAQLaK46-oP8EUKvvjSOpM0aaqwcFn8gos-qM8hN5kuuds2a9Iu3H9vSleFfZB5mGE4Z5gzZ4riJUKNgPLtsZ7tWDNAUYOsAdpHxTmqlldMonicaxBQYcvVWfEspSMAyEbi0-KMyQYaJZvzYv81TFWaKQbvzFCaafaVn_rBjKOZQzyVLi7XKfddaU10PtyZZJfBxDL6dPOu3M2ljSGlGIxLz4snvRkSvbjPF8XPjx9-XH2u9t8-fbna7SvboJqrppOsY8QPAhTr0Sh3EIJ3DARTrUBk_YEaTqrvhO0VAwtcGGylYZJL7Hp-UbzZ5t7G8GuhNOvRJ0vDYCYKS9LYMsWE5K3M0NcPoMewxClvp1Fx3uU7cMyoekNdm4F01h_maGwOR6O3YaLe5_6u4aJrswTIBNwIm3jq9W30o4knjaBXb_RRZ2_06o0GqbM3mfPqfpXlMJL7y_hjRga83wCUb3fnKepkPU2WnI9kZ-2C_-_4ywdsO_jJWzPc0InSP9k6MQ36-_oc62-ggDUL_htNlrFV
sourcetypeAggregation Database
isCDItrue
recordtypearticle
pqid1833940431
display
typearticle
titleNon-steroidal anti-inflammatory drugs and cardiovascular risk: At crossroads
sourceAlma/SFX Local Collection
creatorFarkouh, Michael E., MD, MSc, FRCPC, FACC, FAHA
creatorcontribFarkouh, Michael E., MD, MSc, FRCPC, FACC, FAHA
descriptionByline: Michael E. Farkouh Author Affiliation: Peter Munk Chair in Multinational Clinical Trials, Peter Munk Cardiac Centre and the Heart and Stroke Richard Lewar Centre of Excellence, University of Toronto, Toronto, Ontario, Canada Article Note: (footnote) The author has indicated there are no conflicts of interest.
identifier
0ISSN: 1050-1738
1EISSN: 1873-2615
2DOI: 10.1016/j.tcm.2015.06.007
3PMID: 26404864
languageeng
publisherUnited States: Elsevier Inc
subjectAnti-Inflammatory Agents, Non-Steroidal - adverse effects ; Arthritis ; Aspirin ; Blood platelets ; Blood pressure ; Cardiovascular ; Cardiovascular diseases ; Cardiovascular Diseases - etiology ; Clinical trials ; Cyclooxygenase 1 - metabolism ; Cyclooxygenase 2 - metabolism ; Drug dosages ; Drug therapy ; Female ; Health risk assessment ; Heart attacks ; Humans ; Hypotheses ; Male ; Mortality ; Nonsteroidal anti-inflammatory drugs ; Risk factors ; Side effects ; Studies ; Thrombosis
ispartofTrends in cardiovascular medicine, 2015, Vol.25 (8), p.736-737
rights
0Elsevier Inc.
12015 Elsevier Inc.
2COPYRIGHT 2015 Elsevier B.V.
3Copyright Elsevier Limited 2015
lds50peer_reviewed
citesFETCH-LOGICAL-c418t-496292e3b5082f1a8db55392052875112fbe43e8f95cf820c035a176a263619f3
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
thumbnail$$Usyndetics_thumb_exl
backlink$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26404864$$D View this record in MEDLINE/PubMed
search
creatorcontribFarkouh, Michael E., MD, MSc, FRCPC, FACC, FAHA
title
0Non-steroidal anti-inflammatory drugs and cardiovascular risk: At crossroads
1Trends in cardiovascular medicine
addtitleTrends Cardiovasc Med
descriptionByline: Michael E. Farkouh Author Affiliation: Peter Munk Chair in Multinational Clinical Trials, Peter Munk Cardiac Centre and the Heart and Stroke Richard Lewar Centre of Excellence, University of Toronto, Toronto, Ontario, Canada Article Note: (footnote) The author has indicated there are no conflicts of interest.
subject
0Anti-Inflammatory Agents, Non-Steroidal - adverse effects
1Arthritis
2Aspirin
3Blood platelets
4Blood pressure
5Cardiovascular
6Cardiovascular diseases
7Cardiovascular Diseases - etiology
8Clinical trials
9Cyclooxygenase 1 - metabolism
10Cyclooxygenase 2 - metabolism
11Drug dosages
12Drug therapy
13Female
14Health risk assessment
15Heart attacks
16Humans
17Hypotheses
18Male
19Mortality
20Nonsteroidal anti-inflammatory drugs
21Risk factors
22Side effects
23Studies
24Thrombosis
issn
01050-1738
11873-2615
fulltexttrue
rsrctypearticle
creationdate2015
recordtypearticle
recordideNp9Ul2L1TAQLaK46-oP8EUKvvjSOpM0aaqwcFn8gos-qM8hN5kuuds2a9Iu3H9vSleFfZB5mGE4Z5gzZ4riJUKNgPLtsZ7tWDNAUYOsAdpHxTmqlldMonicaxBQYcvVWfEspSMAyEbi0-KMyQYaJZvzYv81TFWaKQbvzFCaafaVn_rBjKOZQzyVLi7XKfddaU10PtyZZJfBxDL6dPOu3M2ljSGlGIxLz4snvRkSvbjPF8XPjx9-XH2u9t8-fbna7SvboJqrppOsY8QPAhTr0Sh3EIJ3DARTrUBk_YEaTqrvhO0VAwtcGGylYZJL7Hp-UbzZ5t7G8GuhNOvRJ0vDYCYKS9LYMsWE5K3M0NcPoMewxClvp1Fx3uU7cMyoekNdm4F01h_maGwOR6O3YaLe5_6u4aJrswTIBNwIm3jq9W30o4knjaBXb_RRZ2_06o0GqbM3mfPqfpXlMJL7y_hjRga83wCUb3fnKepkPU2WnI9kZ-2C_-_4ywdsO_jJWzPc0InSP9k6MQ36-_oc62-ggDUL_htNlrFV
startdate2015
enddate2015
creatorFarkouh, Michael E., MD, MSc, FRCPC, FACC, FAHA
general
0Elsevier Inc
1Elsevier B.V
2Elsevier Limited
scope
0CGR
1CUY
2CVF
3ECM
4EIF
5NPM
6AAYXX
7CITATION
8BSHEE
93V.
107RV
117TK
127X7
137XB
1488E
158FI
168FJ
178FK
188G5
19ABUWG
20AZQEC
21BENPR
22DWQXO
23FYUFA
24GHDGH
25GNUQQ
26GUQSH
27K9.
28KB0
29M0S
30M1P
31M2O
32MBDVC
33NAPCQ
34PADUT
35PQEST
36PQQKQ
37PQUKI
38PRINS
39Q9U
407X8
sort
creationdate2015
titleNon-steroidal anti-inflammatory drugs and cardiovascular risk: At crossroads
authorFarkouh, Michael E., MD, MSc, FRCPC, FACC, FAHA
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-c418t-496292e3b5082f1a8db55392052875112fbe43e8f95cf820c035a176a263619f3
rsrctypearticles
prefilterarticles
languageeng
creationdate2015
topic
0Anti-Inflammatory Agents, Non-Steroidal - adverse effects
1Arthritis
2Aspirin
3Blood platelets
4Blood pressure
5Cardiovascular
6Cardiovascular diseases
7Cardiovascular Diseases - etiology
8Clinical trials
9Cyclooxygenase 1 - metabolism
10Cyclooxygenase 2 - metabolism
11Drug dosages
12Drug therapy
13Female
14Health risk assessment
15Heart attacks
16Humans
17Hypotheses
18Male
19Mortality
20Nonsteroidal anti-inflammatory drugs
21Risk factors
22Side effects
23Studies
24Thrombosis
toplevel
0peer_reviewed
1online_resources
creatorcontribFarkouh, Michael E., MD, MSc, FRCPC, FACC, FAHA
collection
0Medline
1MEDLINE
2MEDLINE (Ovid)
3MEDLINE
4MEDLINE
5PubMed
6CrossRef
7Academic OneFile (A&I only)
8ProQuest Central (Corporate)
9Nursing & Allied Health Database
10Neurosciences Abstracts
11Health & Medical Collection
12ProQuest Central (purchase pre-March 2016)
13Medical Database (Alumni Edition)
14Hospital Premium Collection
15Hospital Premium Collection (Alumni Edition)
16ProQuest Central (Alumni) (purchase pre-March 2016)
17Research Library (Alumni Edition)
18ProQuest Central (Alumni Edition)
19ProQuest Central Essentials
20ProQuest Central
21ProQuest Central Korea
22Health Research Premium Collection
23Health Research Premium Collection (Alumni)
24ProQuest Central Student
25Research Library Prep
26ProQuest Health & Medical Complete (Alumni)
27Nursing & Allied Health Database (Alumni Edition)
28Health & Medical Collection (Alumni Edition)
29Medical Database
30Research Library
31Research Library (Corporate)
32Nursing & Allied Health Premium
33Research Library China
34ProQuest One Academic Eastern Edition
35ProQuest One Academic
36ProQuest One Academic UKI Edition
37ProQuest Central China
38ProQuest Central Basic
39MEDLINE - Academic
jtitleTrends in cardiovascular medicine
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
auFarkouh, Michael E., MD, MSc, FRCPC, FACC, FAHA
formatjournal
genrearticle
ristypeJOUR
atitleNon-steroidal anti-inflammatory drugs and cardiovascular risk: At crossroads
jtitleTrends in cardiovascular medicine
addtitleTrends Cardiovasc Med
date2015
risdate2015
volume25
issue8
spage736
epage737
pages736-737
issn1050-1738
eissn1873-2615
abstractByline: Michael E. Farkouh Author Affiliation: Peter Munk Chair in Multinational Clinical Trials, Peter Munk Cardiac Centre and the Heart and Stroke Richard Lewar Centre of Excellence, University of Toronto, Toronto, Ontario, Canada Article Note: (footnote) The author has indicated there are no conflicts of interest.
copUnited States
pubElsevier Inc
pmid26404864
doi10.1016/j.tcm.2015.06.007